CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Crypto risk tolerance score helps you gauge how much crypto volatility you can handle. This intro explains the score and how to use it to shape your strategy.
26,292 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Markets swing, but smart investors seek durable growth. This article highlights three names with a credible path to m...
A big order from China could reshape Boeing's outlook and affect your investments. This guide breaks down the implica...
Soccer's biggest tournament is moving to North America in 2026 with an expanded field and a booming betting market. T...
A biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
A major portfolio move by Deepwater Asset Management shaved nearly half of its stake in Global-E Online. Here’s what ...
As coastal rents climb, a growing number of investors are testing a bold concept: a $310,000 portfolio that pays enou...
Rivian is targeting a major production shift with the R2 lineup. This guide weighs the bull and bear cases for rivian...
Looking for the best-performing tech stocks this week? This guide breaks down how to spot momentum, what to watch, an...
Space stocks can swing on headlines and momentum. This article explains why rocket stock popped then dropped, what dr...
A five-year restraining order against a persistent admirer shows how safety, law, and money intersect. Learn practica...
Rumors around chip supply and product timelines can move markets quickly. This guide shows how AMD typically responds...